
One hundred twelve patients who developed acute leukemia or a zzso syndrome zzso after chemotherapy or zzso for another zzso were zzso The median time from initial therapy to development of secondary leukemia or zzso was 71 months zzso 7 to 331 zzso The initial zzso was zzso in zzso An zzso presentation occurred in 57 patients zzso zzso of whom subsequently transformed to acute zzso zzso abnormalities were documented in zzso specimens from 70 of 89 patients with zzso zzso zzso zzso of the total zzso Compared with 34 patients with zzso secondary leukemia without prior chemotherapy or zzso those with zzso leukemia exhibited a significantly higher frequency of abnormalities of zzso 5 and/or 7 zzso v zzso and lower zzso of zzso zzso zzso v zzso zzso 5 and/or 7 abnormalities were also significantly higher in patients previously treated with zzso agents, zzso and zzso zzso to zzso compared with those who had received zzso regimens zzso other zzso zzso or zzso alone zzso The median overall survival from diagnosis of the secondary leukemia or zzso was 30 zzso Survival was significantly shorter for patients with acute leukemia compared with zzso presentation (21 v 45 zzso in the latter category, it was similar whether evolution to acute leukemia occurred or zzso Of 72 patients treated with zzso therapy, zzso achieved complete zzso zzso A zzso analysis of zzso factors demonstrated the zzso pattern to be the most important characteristic determining zzso rate and zzso Other important zzso features were the zzso presentation zzso v acute zzso for probability of achieving zzso and patient age and zzso blasts percentage for zzso 

